2012
|
Invention
|
Heteroalkyl linked pyrimidine derivatives. The present invention relates to pyrimidine compounds ... |
2011
|
Invention
|
Solid state forms of macrocyclic kinase inhibitors. Provided herein are salt forms of macrocyclic... |
2010
|
Invention
|
Bridged morpholino substituted purines. The present invention relates to purine compounds that ar... |
|
Invention
|
9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18... |
|
Invention
|
8-substituted-2-morpholino purines for use as pi3k and/or mtor inhibitors in the treatment of pro... |
2009
|
Invention
|
11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa... |
|
Invention
|
11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacos... |
|
Invention
|
Pyrazine substituted purines.
The present invention relates to purine compounds of formula (I) t... |
|
Invention
|
Pyrazine substituted purines. The present invention relates to purine compounds of formula (I) th... |
|
Invention
|
Pyrimidine substituted purine compounds as kinase (s) inhibitors. The present invention relates t... |
|
Invention
|
Triazine compounds as kinase inhibitors. The present invention relates to triazine compounds that... |
2008
|
Invention
|
2-morpholinylpurines as inhibitors of pi3k.
The present invention relates to purine compounds th... |
|
Invention
|
Pyrimidine substituted purine derivatives. The present invention relates to purine compounds that... |
|
Invention
|
2-morpholinylpurines as inhibitors of pi3k. The present invention relates to purine compounds tha... |
|
Invention
|
Pyridyl substituted pyrimidine derivatives. The present invention relates to pyridyl substituted ... |
|
Invention
|
Pyrimidine derivatives. The present invention relates to pyrimidine compounds that are useful as ... |
|
Invention
|
Heterocycloalkyl substituted pyrimidine derivatives. The present invention relates to pyrimidine ... |
|
Invention
|
Combination of benzimidazole anti-cancer agent and a second anti-cancer agent.
The present inven... |
|
Invention
|
Combination of benzimidazole anti-cancer agent and a second anti-cancer agent. The present invent... |
2007
|
Invention
|
Indole sustituted pyrimidines and use thereof in the treatment of cancer. The present invention r... |
2006
|
Invention
|
Indazole compounds. The present invention relates to indazole compounds which are useful in the t... |
|
Invention
|
Oxygen linked pyrimidine derivatives. The present invention relates to pyrimidine compounds that ... |
|
Invention
|
Method of predicting a response to hdac inhibitors. The present invention provides a method for p... |
|
Invention
|
Imidazo⏧l,2-a]pyridine hydroxymate compounds that are inhibitors of histone deacetylase. The... |
|
Invention
|
Heterocyclic compounds. The present invention relates to compounds which are inhibitors of histon... |
|
Invention
|
Benzothiophene derivatives: preparation and pharmaceutical applications. The present invention re... |
|
Invention
|
Imidazo⏧1,2-a]pyridine derivatives: preparation and pharmaceutical applications. The present... |
|
Invention
|
Bicyclic heterocycles hydroxamate compounds useful as histone deacetylase (hdac) inhibitors. The ... |
2004
|
Invention
|
Acylurea connected and sulfonylurea connected hydroxamates.
The present invention relates to hyd... |
|
Invention
|
Acylurea connected and sulfonylurea connected hydroxamates. The present invention relates to hydr... |
|
Invention
|
Biaryl linked hydroxamates: preparation and pharmaceutical applications. The present invention re... |
|
Invention
|
Benzimidazole derivates: preparation and pharmaceutical applications. The present invention relat... |